Abstract
Recent studies have shown that inflammatory bowel disease (IBD) patients are affected by altered body composition, especially low muscle mass or sarcopenia. Detection of sarcopenia is important, as it can independently predict osteopenia, sarcopenic obesity, and poor disease outcomes during IBD progress. The challenges are needed to identify diagnostic and managing strategies for sarcopenia in IBD to improve disease outcomes and increase the quality of life in patients with IBD.
| Original language | English |
|---|---|
| Pages (from-to) | 308-314 |
| Number of pages | 7 |
| Journal | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi |
| Volume | 71 |
| Issue number | 6 |
| DOIs | |
| State | Published - 25 Jun 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Body composition
- Bone diseases, metabolic
- Inflammatory bowel disease
- Obesity
- Sarcopenia
Fingerprint
Dive into the research topics of 'Clinical Implication of Sarcopenia in Patients with Inflammatory Bowel Disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver